Docebo Inc.
DCBO
$21.78
$0.180.83%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 236.69M | 230.50M | 222.82M | 216.93M | 209.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 236.69M | 230.50M | 222.82M | 216.93M | 209.17M |
| Cost of Revenue | 46.13M | 44.43M | 43.01M | 41.54M | 40.05M |
| Gross Profit | 190.56M | 186.08M | 179.82M | 175.40M | 169.12M |
| SG&A Expenses | 115.78M | 115.21M | 111.99M | 108.64M | 106.95M |
| Depreciation & Amortization | 3.25M | 3.39M | 3.36M | 3.38M | 3.07M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.55M | 211.62M | 204.82M | 197.03M | 191.15M |
| Operating Income | 22.14M | 18.88M | 18.01M | 19.90M | 18.02M |
| Income Before Tax | 23.68M | 20.77M | 21.30M | 23.71M | 18.63M |
| Income Tax Expenses | 1.11M | -647.00K | -1.74M | -3.02M | 584.00K |
| Earnings from Continuing Operations | 22.57 | 21.42 | 23.04 | 26.74 | 18.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.57M | 21.42M | 23.04M | 26.74M | 18.05M |
| EBIT | 22.14M | 18.88M | 18.01M | 19.90M | 18.02M |
| EBITDA | 23.51M | 20.81M | 20.40M | 22.79M | 21.27M |
| EPS Basic | 0.76 | 0.71 | 0.76 | 0.88 | 0.59 |
| Normalized Basic EPS | 0.52 | 0.45 | 0.46 | 0.51 | 0.38 |
| EPS Diluted | 0.74 | 0.69 | 0.74 | 0.86 | 0.57 |
| Normalized Diluted EPS | 0.51 | 0.44 | 0.45 | 0.50 | 0.37 |
| Average Basic Shares Outstanding | 118.79M | 120.26M | 121.05M | 121.11M | 122.79M |
| Average Diluted Shares Outstanding | 121.56M | 123.04M | 123.87M | 123.99M | 125.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |